Boggon, Titus Jonathon
- Yale University · Pharmacology (NIH department code)
- Massachusetts General Hospital (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #10,593
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$973.7K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#10,593
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Boggon, Titus Jonathon as a PI. Multi-PI records show the full award amount for context.
- 5R01NS117609-04R01Contact PIHuman Genetics and Molecular Mechanisms of Vein of Galen Aneurysmal Malformation$553Kaward amount
- 5R01GM138411-04R01Contact PIP21-activated kinases in cell-cell and cell-matrix adhesion signalingYale University · Pharmacology (NIH department code)$420.7Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Boggon, Titus Jonathon as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardMassachusetts General Hospital
- 2010$500K Cumulative Funding
- 2010Multi-Institutional ResearchAwards at 2 institutions
- 2011$1M Cumulative Funding
- 2013R01 Grant Holder
- 2014$2M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #7284
- 2021$5M Cumulative Funding